Immuno Cure secures HK$8 M funding support for HIV vaccine clinical trial

Immuno Cure BioTech, a clinical stage biotechnology group based in the Hong Kong Science Park specialising in DNA vaccin...

October 18, 2022 | Tuesday | News
EU recommends approval of Takeda's dengue vaccine

Japanese pharmaceutical firm Takeda has announced that the Committee for Medicinal Products for Human Use...

October 18, 2022 | Tuesday | News
We are advancing two bivalent candidates for utilisation in global vaccination efforts

Singapore Health Sciences Authority (HSA) has granted an interim authorisation for the use of Moderna’s Omicr...

October 7, 2022 | Friday | Opinion
IVI announces 'vaccines partnership' with London School of Hygiene & Tropical Medicine

South Korea-based International Vaccine Institute (IVI) and the London School of Hygiene & Tropical Medicine (LSHTM)...

October 4, 2022 | Tuesday | News
IVI partners with Hilleman to advance vaccine R&D and manufacturing

South Korea-based International Vaccine Institute (IVI) has signed a three-year Memorandum of Understanding (MoU) with H...

October 4, 2022 | Tuesday | News
Global Health and Gavi Veteran Anuradha Gupta to lead Global Immunization at Sabin

Veteran public health leader Anuradha Gupta, who has spearheaded a host of successful global initiatives to improve the ...

October 4, 2022 | Tuesday | News
Indonesia's Bio Farma secures UNICEF contract for oral polio vaccine type 2

Indonesia's PT Bio Farma (Persero), the holding company for pharmaceutical state-owned enterprises (SOEs), will export i...

October 4, 2022 | Tuesday | News
Australia leads research to develop next generation of TB vaccines

The University of Sydney and The Centenary Institute, together with collaborators have been awarded an AU$19 million con...

September 30, 2022 | Friday | News
Australia invests in new study on COVID-19 vaccines with future variants emerging

The Australian government is investing in a new study on COVID-19 vaccines and infection to ultimately improve the care ...

September 26, 2022 | Monday | News
Singapore grants interim authorisation for first bivalent COVID-19 booster vaccine

Singapore Health Sciences Authority (HSA) has granted an interim authorisation for the use of Moderna’s Omicr...

September 14, 2022 | Wednesday | News
Australia explores use of vaccinia virus-based vaccines to fight monkeypox

New research suggests recommended vaccinia virus (VACV)-based vaccines will mount a robust immune response against the m...

September 13, 2022 | Tuesday | News
China approves inhaled vaccine as COVID-19 booster dose

CanSino Biologics Inc has announced that the National Medical Products Administration of China (NMPA) has granted the co...

September 12, 2022 | Monday | News
Indonesian firm Bio Farma set to launch IndoVac COVID-19 vaccine

PT Bio Farma, the holding company for state-owned pharmaceutical companies in Indonesia, has nnounced a new milestone in...

September 12, 2022 | Monday | News
Polyplus Builds on Research and Commercial mRNA Support Portfolio with in vivo-jetRNA®+ Transfection Reagent

The new in vivo-jetRNA®+ transfection reagent an efficient, stable, and safe delivery system leading to 100% mR...

September 8, 2022 | Thursday | News
Bharat Biotech's COVID-19 intranasal vaccine gets 'emergency use' approval in India

Indian firm Bharat Biotech has announced that iNCOVACC (BBV154) has received approval under Restricted Use in Emergency ...

September 7, 2022 | Wednesday | News
China's Sinovac makes progress with trivalent COVID-19 vaccine

China-based Sinovac Biotech has announced that the Chilean Public Health Institute (Instituto de Salud Pública, I...

September 7, 2022 | Wednesday | News
Indonesia approves Takeda's dengue vaccine

Japanese firm Takeda has announced that the company’s dengue vaccine, QDENGA (Dengue Tetravalent Vaccine [Live, At...

August 23, 2022 | Tuesday | News
Moderna to build first mRNA production facility in Southern Hemisphere

Australia's Monash University has announced that US-based firm Moderna will be joining other world-leading research and ...

August 16, 2022 | Tuesday | News